MergerLinks Header Logo

Submit Deal

Submit Deal

Cover Image Michael Matin
Michael MatinHDL THERAPEUTICS INC

Michael Matin

Chairman and CEO at HDL THERAPEUTICS INC

Manager

Deal Bio

Total Deals1
Valued Deals1
Total Value£ 378 M
Avg. Deal Size£ 378 M

Market Context

Sort

24 Apr 2023|United States|Biotechnology
Hdl Therapeutics
Swiftmerge Acquisition

Target: HDL THERAPEUTICS INC

Bidder: SWIFTMERGE ACQUISITION

4 Service Providers

2 Target | 2 Bidder

6 Dealmakers

5 Target | 1 Bidder

£ 378 M

Value

Privacy PolicyTerms of ServiceContact UsCookie Preferences

All rights reserved. Copyright © 2025 Datasite